SCOR announced that an arbitration tribunal confirmed the validity of reinsurance treaties made with Covéa in June 2021, involving the transfer of 30% of SCOR's Life & Health portfolio. The tribunal ruled in favor of Covéa, awarding $488.3 million in compensation. This decision will affect SCOR's net result by approximately €50 million in Q2 2026 but will not impact its solvency or liquidity ratios. SCOR will continue to implement its Forward 2026 plan focusing on financial resilience and underwriting discipline amid a competitive market.
The QAIAx AI City Hall Project has launched the world's first federally registered clinical trial involving AI-governed smart microcities. These dome-enclosed communities integrate humanoid robots and quantum AI to manage public administration and pr...
SCOR announced that an arbitration tribunal upheld the validity of retrocession treaties made with Covéa in June 2021, involving the transfer of 30% of SCOR's Life & Health portfolio in Ireland. The tribunal awarded Covéa compensation of USD 488.3 mi...
Lifestyle expert Marisa Brahney highlights simple and fun ways to celebrate America's 250th birthday this summer, including enjoying Northwest-grown sweet cherries, affordable travel with Travelodge by Wyndham near national parks, and supporting Amer...
Woodward, Inc. announced a quarterly cash dividend of $0.32 per share, payable on September 3, 2026, to shareholders of record as of August 20, 2026. This dividend reflects the company's ongoing commitment to returning value to shareholders. Woodward...
MEDIROM MOTHER Labs has expanded its deployment of the REMONY® remote health monitoring system, equipped with the recharge-free MOTHER Bracelet®, in the Japan Ground Self-Defense Force (JGSDF) 8th Division. The additional order triples the scale of t...
